Advertisement

Multimodality imaging of usual and unusual sites of metastasis which occur after definitive therapy for rectal cancer

  • Priya Bhosale
    Correspondence
    Corresponding author. Division of Diagnostic Imaging, Department of Radiology, University of Texas M. D. Anderson Cancer Center, Box 368, Houston, TX 77030, USA. Tel.: +1 713 792 8177; fax: +1 713 745 1302.
    Affiliations
    MD Anderson Cancer Research Center, Division of Diagnostic Imaging, 1515 Holcomb Street, Houston, TX 77401, USA
    Search for articles by this author
  • Janio Szklaruk
    Affiliations
    MD Anderson Cancer Research Center, Division of Diagnostic Imaging, 1515 Holcomb Street, Houston, TX 77401, USA
    Search for articles by this author
  • Revathy Iyer
    Affiliations
    MD Anderson Cancer Research Center, Division of Diagnostic Imaging, 1515 Holcomb Street, Houston, TX 77401, USA
    Search for articles by this author

      Abstract

      Rectal cancer is a common malignancy encountered largely after the fifth decade of life. Due to the recent advances in cancer therapy, which include chemoradiation therapy pre- and postoperatively, survival has improved. Radiologist has become an integral part of the patient management team to diagnose and localize the area of recurrent rectal cancer. Although typical pathways of rectal cancer spread have been described, recurrence may occur in unexpected locations due to the currently available aggressive therapy being able to control local disease. Imaging surveillance should include careful evaluation of expected and unexpected anatomic sites where tumor may recur. This paper will describe the common and uncommon locations of recurrent rectal cancer.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Iafrate F
        • Laghi A
        • Paolantonio P
        • et al.
        Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings.
        Radiographics. 2006; 26: 701-714
        • Kim JH
        • Beets GL
        • Kim MJ
        • Kessels AG
        • Beets-Tan RG
        High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?.
        Eur J Radiol. 2004; 52: 78-83
        • Cancer of the Colon and Rectum
        Sheets S.S.F. National Cancer Institute, 2007 (http://seer.cancer.gov/statfacts/html/colorect.html)
      1. Colorectal cancer (PDQ): prevention health professional version. National Cancer Institute, 2007 (http://seer.cancer.gov/studies/surveillance/study3.html.)
        • Shike M
        • Winawer SJ
        • Greenwald PH
        • Bloch A
        • Hill MJ
        • Swaroop SV
        Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer.
        Bull World Health Organ. 1990; 68: 377-385
        • Endreseth BH
        • Romundstad P
        • Myrvold HE
        • Hestvik UE
        • Bjerkeset T
        • Wibe A
        Rectal cancer in the young patient.
        Dis Colon Rectum. 2006; 49: 993-1001
        • Thoeni RF
        • Moss AA
        • Schnyder P
        • Margulis AR
        Detection and staging of primary rectal and rectosigmoid cancer by computed tomography.
        Radiology. 1981; 141: 135-138
        • Sinha R
        • Verma R
        • Rajesh A
        • Richards CJ
        Diagnostic value of multidetector row CT in rectal cancer staging: comparison of multiplanar and axial images with histopathology.
        Clin Radiol. 2006; 61: 924-931
        • Das P
        • Skibber JM
        • Rodriguez-Bigas MA
        • et al.
        Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
        Am J Clin Oncol. 2006; 29: 219-224
        • Welch JP
        • Donaldson GA
        The clinical correlation of an autopsy study of recurrent colorectal cancer.
        Ann Surg. 1979; 189: 496-502
        • Goldstein MJ
        • Mitchell EP
        Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.
        Cancer Invest. 2005; 23: 338-351
        • Krestin GP
        • Steinbrich W
        • Friedmann G
        Diagnosis of recurrent rectal cancer: comparison of CT and MR.
        Rofo. 1988; 148: 28-33
        • Schaefer O
        • Langer M
        Detection of recurrent rectal cancer with CT, MRI and PET/CT.
        Eur Radiol. 2007; 17: 2044-2054
        • Larsen SG
        • Wiig JN
        • Giercksky KE
        Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
        Am J Surg. 2005; 190: 55-60
        • Di Bartolomeo N
        • Balestra MR
        • Liddo G
        • Innocenti P
        Pelvic recurrence of rectal cancer: our experience.
        Suppl Tumori. 2005; 4: S21-S23
        • Sadahiro S
        • Suzuki T
        • Ishikawa K
        • et al.
        Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
        Hepatogastroenterology. 2003; 50: 1362-1366
        • Torricelli P
        • Pecchi A
        • Luppi G
        • Romagnoli R
        Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
        Abdom Imaging. 2003; 28: 19-27
        • Wood TF
        • Saha S
        • Morton DL
        • et al.
        Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques.
        Ann Surg Oncol. 2001; 8: 150-157
        • Koh DM
        • Brown G
        • Temple L
        • et al.
        Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings—initial observations.
        Radiology. 2004; 231: 91-99
        • Lewis MR
        • Deavers MT
        • Silva EG
        • Malpica A
        Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge.
        Am J Surg Pathol. 2006; 30: 177-184
        • Kanthan R
        • Loewy J
        • Kanthan SC
        Skeletal metastases in colorectal carcinomas: a Saskatchewan profile.
        Dis Colon Rectum. 1999; 42: 1592-1597
        • Sarid D
        • Wigler N
        • Gutkin Z
        • Merimsky O
        • Leider-Trejo L
        • Ron IG
        Cutaneous and subcutaneous metastases of rectal cancer.
        Int J Clin Oncol. 2004; 9: 202-205
        • Cheng C
        • Rodriguez-Bigas MA
        • Petrelli N
        Is there a role for curative surgery for pelvic recurrence from rectal carcinoma in the presence of hydronephrosis?.
        Am J Surg. 2001; 182: 274-277
        • Rodriguez-Bigas MA
        • Herrera L
        • Petrelli NJ
        Surgery for recurrent rectal adenocarcinoma in the presence of hydronephrosis.
        Am J Surg. 1992; 164: 18-21
        • Martin M
        • Diaz-Rubio E
        Control of colorectal cancer recurrence treated with curative surgery: results of a prospective study.
        Rev Clin Esp. 1991; 188: 339-344
        • Garcia-Aguilar J
        • Cromwell JW
        • Marra C
        • Lee SH
        • Madoff RD
        • Rothenberger DA
        Treatment of locally recurrent rectal cancer.
        Dis Colon Rectum. 2001; 44: 1743-1748